Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- IsoCOMFORTIndependent statistical analysis of Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Isoflurane Preconditioning for Liver Resections: Complete Statistical AnalysisIndependent statistical analysis of Isoflurane Preconditioning for Liver Resections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01031550).
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IsradipineIndependent statistical analysis of Adjunctive Isradipine for the Treatment of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01784666).
- ISS-DMIIIndependent statistical analysis of Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ISTEPIndependent statistical analysis of Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860818).
- iSTEP – an mHealth Physical Activity and Diet Intervention for Persons With HIV: Complete Statistical AnalysisIndependent statistical analysis of iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): Complete Statistical AnalysisIndependent statistical analysis of Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ISV-305Independent statistical analysis of 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Itacitinib + Everolimus in Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib + Everolimus in Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03697408).
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: primary endpoint…
- iTAP-VIndependent statistical analysis of The Insomnia Treatment and Problems Study for Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03804788).
- iTBS Study for Depression (Randomized): Complete Statistical AnalysisIndependent statistical analysis of iTBS Study for Depression (Randomized): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03745768).
- ITDIndependent statistical analysis of Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ITICIndependent statistical analysis of A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size…
- iTOMIndependent statistical analysis of Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ITPIndependent statistical analysis of Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00699140).
- iTransition Development: Complete Statistical AnalysisIndependent statistical analysis of iTransition Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04383223).
- ITT4Independent statistical analysis of ITT4 Intratesticular Hormonal Milieu in Man (ITT4): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215292).
- ITUIndependent statistical analysis of ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255733).
- IU-CHOICEIndependent statistical analysis of Indiana University Dementia Screening Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01699503).
- IUDIndependent statistical analysis of Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IUD@CSDIndependent statistical analysis of Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155738).
- IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400580).
- IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IV APAP SFIndependent statistical analysis of Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia: Complete Statistical AnalysisIndependent statistical analysis of IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01200069).
- IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures: Complete Statistical AnalysisIndependent statistical analysis of IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: Complete Statistical AnalysisIndependent statistical analysis of IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IV TylenolIndependent statistical analysis of IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- iVASTIndependent statistical analysis of The Intra-arterial Vasospasm Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01996436).
- Ivermectin and Human Immunity: Complete Statistical AnalysisIndependent statistical analysis of Ivermectin and Human Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03459794).
- IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing: Complete Statistical AnalysisIndependent statistical analysis of IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02026193).
- IVHIndependent statistical analysis of Tortle Midliner and Intraventricular Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03543046).
- IVIDAIndependent statistical analysis of Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: Complete Statistical AnalysisIndependent statistical analysis of IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03401073).
- IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697292).
- IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff: Complete Statistical AnalysisIndependent statistical analysis of IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ivWatch Model 400: Device Validation for Non-Infiltrated Tissues: Complete Statistical AnalysisIndependent statistical analysis of ivWatch Model 400: Device Validation for Non-Infiltrated Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120443).
- ivWatch Sensor: Device Validation for Infiltrated Tissues: Complete Statistical AnalysisIndependent statistical analysis of ivWatch Sensor: Device Validation for Infiltrated Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04064229).
- IVYIndependent statistical analysis of A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IWPIndependent statistical analysis of Immigrant Well-being Project: Transdisciplinary Ecological Mental Health Intervention for Mexican Immigrants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IWWPIndependent statistical analysis of It's WeWomen Plus Intervention for Health, Safety and Empowerment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04098276).
- IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE): Complete Statistical AnalysisIndependent statistical analysis of IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ixabepilone in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ixabepilone in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00087139).
- Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00095979).
- Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…